Asia-Pacific bone marrow biopsy market is projected to register a substantial CAGR of 6.3% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation:
Asia-Pacific Bone Marrow Biopsy Market, By Product Type (Needles, Instruments, Biopsy Gun, Procedure Trays, Others), Procedure Type (Hip Biopsy, Breastbone (Sternum) Biopsy, Percutaneous Trephine Biopsy, Tibia (Shin) Biopsy, Others), Biopsy Type (Core Needle Biopsy, Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy), Site (Posterior Iliac Crest, Anterior Iliac Crest, Calcaneus, Distal Tibia, Proximal Tibia, Proximal Humerus, Others), Technique (Flow Cytometry, Fluorescence In Situ Hybridization (Fish), Polymerase Chain Reaction (PCR), Karyotype Test, Other), Age (Geriatric, Adult, Pediatric), Application (Lymphoma Disease, Leukemia, Polycythemia Vera, Multiple Myeloma, Thrombocythemia, Myelofibrosis, Aplastic Anemia, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Organizations, Others), Distribution Channel (Direct Tender, Retail Sales), Country (China, Japan, India, South Korea, Australia, Indonesia, Thailand, Malaysia, Singapore, Philippines, Rest of Asia-Pacific) Industry Trends & Forecast to 2027
Some of the major factors contributing to the growth of the Asia-Pacific bone marrow biopsy market are:
• Increase in diagnosis rate of cancer
• Extensive research & development activities
Market Players:
The key market players for Asia-Pacific bone marrow biopsy market are listed below:
• BD
• Medtronic
• Argon Medical
• Merit Medical Systems
• Cardinal Health
• Teleflex Incorporated
• Cook
• Hiprove
• Shanghai Mekon Medical Devices Co., Ltd.
• SOMATEX Medical Technologies GmbH